The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19

OBJECTIVE: During the COVID-19 pandemic the continuation or cessation of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) has been contentious. Mechanisms have been proposed for both beneficial and detrimental effects. Recent studies have focused on mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Braude, Philip, Carter, Ben, Short, Roxanna, Vilches-Moraga, Arturo, Verduri, Alessia, Pearce, Lyndsay, Price, Angeline, Quinn, Terence J., Stechman, Michael, Collins, Jemima, Bruce, Eilidh, Einarsson, Alice, Rickard, Frances, Mitchell, Emma, Holloway, Mark, Hesford, James, Barlow-Pay, Fenella, Clini, Enrico, Myint, Phyo Kyaw, Moug, Susan, McCarthy, Kathryn, Hewitt, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561344/
https://www.ncbi.nlm.nih.gov/pubmed/33083516
http://dx.doi.org/10.1016/j.ijcha.2020.100660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561344/
https://www.ncbi.nlm.nih.gov/pubmed/33083516
http://dx.doi.org/10.1016/j.ijcha.2020.100660

Ejemplares similares